| Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial F Koehler, K Koehler, O Deckwart, S Prescher, K Wegscheider, BA Kirwan, ... The Lancet 392 (10152), 1047-1057, 2018 | 681 | 2018 |
| Molecular targets of tea polyphenols in the cardiovascular system V Stangl, H Dreger, K Stangl, M Lorenz Cardiovascular research 73 (2), 348-358, 2007 | 317 | 2007 |
| Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection H Dreger, K Westphal, A Weller, G Baumann, V Stangl, S Meiners, ... Cardiovascular research 83 (2), 354-361, 2009 | 274 | 2009 |
| CT or invasive coronary angiography in stable chest pain P Maurovich-Horvat, M Bosserdt, KF Kofoed, N Rieckmann, T Benedek, ... New England Journal of Medicine 386 (17), 1591-1602, 2022 | 245 | 2022 |
| Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial M Dewey, M Rief, P Martus, B Kendziora, S Feger, H Dreger, S Priem, ... bmj 355, 2016 | 143 | 2016 |
| Pacing-induced cardiomyopathy in patients with right ventricular stimulation for> 15 years H Dreger, K Maethner, H Bondke, G Baumann, C Melzer Europace 14 (2), 238-242, 2012 | 141 | 2012 |
| Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study A Lauten, HR Figulla, A Unbehaun, N Fam, J Schofer, T Doenst, ... Circulation: Cardiovascular Interventions 11 (2), e006061, 2018 | 138 | 2018 |
| Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2 H Dreger, K Westphal, N Wilck, G Baumann, V Stangl, K Stangl, ... Cardiovascular research 85 (2), 395-403, 2010 | 125 | 2010 |
| Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system S Meiners, H Dreger, M Fechner, S Bieler, W Rother, C Günther, ... Hypertension 51 (2), 302-308, 2008 | 120 | 2008 |
| Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography study S Schattke, F Knebel, A Grohmann, H Dreger, F Kmezik, G Riemekasten, ... Cardiovascular Ultrasound 8, 1-9, 2010 | 116 | 2010 |
| Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers F Knebel, I Schimke, S Schroeckh, H Peters, S Eddicks, S Schattke, ... Journal of the American Society of Echocardiography 22 (7), 803-809, 2009 | 108 | 2009 |
| Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells S Meiners, A Ludwig, M Lorenz, H Dreger, G Baumann, V Stangl, K Stangl Free Radical Biology and Medicine 40 (12), 2232-2241, 2006 | 99 | 2006 |
| The esc-eorp euro-endo (european infective endocarditis) registry G Habib, P Lancellotti, PA Erba, A Sadeghpour, M Meshaal, A Sambola, ... European Heart Journal-Quality of Care and Clinical Outcomes 5 (3), 202-207, 2019 | 83 | 2019 |
| Two-dimensional speckle tracking of the left ventricle in patients with systemic sclerosis for an early detection of myocardial involvement S Spethmann, H Dreger, S Schattke, G Riemekasten, AC Borges, ... European Heart Journal–Cardiovascular Imaging 13 (10), 863-870, 2012 | 75 | 2012 |
| Cardiac and renal function in a large cohort of amateur marathon runners B Hewing, S Schattke, S Spethmann, W Sanad, S Schroeckh, I Schimke, ... Cardiovascular Ultrasound 13, 1-8, 2015 | 74 | 2015 |
| Transesophageal echocardiography in patients with cryptogenic cerebral ischemia F Knebel, F Masuhr, W von Hausen, T Walde, H Dreger, V Raab, ... Cardiovascular Ultrasound 7, 1-8, 2009 | 68 | 2009 |
| Improved left ventricular structure and function after successful kidney transplantation B Hewing, AM Dehn, O Staeck, F Knebel, S Spethmann, K Stangl, ... Kidney and Blood Pressure Research 41 (5), 701-709, 2016 | 66 | 2016 |
| Characteristics of catechin-and theaflavin-mediated cardioprotection H Dreger, M Lorenz, A Kehrer, G Baumann, K Stangl, V Stangl Experimental Biology and Medicine 233 (4), 427-433, 2008 | 64 | 2008 |
| Recovery of left ventricular and left atrial mechanics in various entities of aortic stenosis 12 months after TAVI S Spethmann, G Baldenhofer, H Dreger, K Stüer, W Sanad, ... European Heart Journal–Cardiovascular Imaging 15 (4), 389-398, 2014 | 63 | 2014 |
| Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells H Dreger, A Ludwig, A Weller, V Stangl, G Baumann, S Meiners, K Stangl Hypertension 60 (5), 1176-1183, 2012 | 63 | 2012 |
Karl StanglProf. Dr., Klinikdirektor Charité Universitätsmedizin BerlinE-mail megerősítve itt: charite.de
